NEW YORK (GenomeWeb) – BG Medicine today said that its fourth quarter revenues were nearly halved year over year as both product and service revenues declined. 

The company separately announced that it filed a 510(k) premarket notification for clearance of an additional indication for the BGM Galectin-3 test. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.